G 224 (Lithium Carbonate Extended Release 450 mg)

Pill with imprint G 224 is Yellow, Round and has been identified as Lithium carbonate extended release 450 mg. It is supplied by Glenmark Generics Inc..

Lithium is used in the treatment of bipolar disorder; borderline personality disorder; schizoaffective disorder; mania; cluster headaches (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 450 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for G 224

Lithium carbonate extended release

Imprint:

G 224

Strength:

450 mg

Color:

Yellow

Shape:

Round

Availability:

Prescription only

Drug Class:

Miscellaneous antipsychotic agents

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Glenmark Generics Inc.

Inactive Ingredients:

sodium alginate
microcrystalline cellulose
ferric oxide yellow
isopropyl alcohol
magnesium silicate
magnesium stearate
sodium starch glycolate type A potato
hypromelloses
Note: Inactive ingredients may vary.

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.